You are here

Healthcare Economics

 

The incentives in CMS programs may have led to unintended consequences.

Performance-based risk-sharing deals allow payers to hedge their bets with new drugs while helping pharmaceutical companies grow market share.

If the Centers for Medicare & Medicaid Services (CMS) weighted 30-day readmissions and mortality equally, financial penalties in 2014 for U.S. hospitals would have substantially changed, according to an analysis of publicly available hospital data.

A recent analysis of that study suggests that intensive blood pressure management may be cost-effective for adults who are at least 50 years old, have hypertension but do not have diabetes and are at high risk for cardiovascular disease.

 

Recent Headlines

Boston Scientific acquires tissue business for use in transcatheter heart valves

Boston Scientific has agreed to acquire a 15 percent equity stake in Neovasc, as well as the company’s advanced biological tissue business for $75 million in cash.

An overview of new payment models for cardiologists

During the past few years, payers have shifted away from fee-for-service payment models and started holding clinicians more responsible for collaborating, keeping costs down and improving the quality of care. A recent review suggests that early adopters of the alternative payment models could benefit in the future when the models become more popular and penalties increase.

Edwards Lifesciences to acquire Valtech Cardio for up to $690 million

Edwards Lifesciences has agreed to acquire Valtech Cardio in a cash and stock deal valued at $340 million at closing, which is expected early next year.

Medtronic releases detailed report on FY2016

For fiscal year (FY) 2016, Medtronic generated $28.8 billion in revenue and $3.5 billion in net earnings and achieved several milestones pertaining to research and philanthropy.

Shockwave Medical receives $45 million in financing

Shockwave Medical has received $45 million in Series C financing, which the company plans to use to develop the its lithoplasty balloon catheter platform.

9 strategies for combating physician burnout

Physicians suffer more burnout at rates much higher than the typical American worker—and their exhaustion is causing medical errors and costing hospitals money. 

Remote cardiac monitoring company to pay $1.35 million to resolve kickback allegations

MedNet, a remote cardiac monitoring company, agreed to pay more than $1.35 million to resolve kickback and false Medicare claims allegations. The U.S. Attorney’s office in New Jersey announced the settlement Nov. 15 and said there had been no determination of liability.

Interventional cardiology, peripheral vascular devices market to reach $25 billion by 2022

The market for interventional cardiology and peripheral vascular devices is expected to grow at a compound annual growth rate of 9.7 percent from 2016 to 2022, reaching $25 billion by 2022.

AHA 2016: Retail prices of generic heart failure drugs vary considerably

The prices of three common generic drugs for heart failure vary considerably among retail pharmacists, according to an analysis 153 chain and 22 independent pharmacies in Missouri and Illinois. Guidelines recommend each of the three medications (digoxin, lisinopril and carvedilol) for patients with heart failure.

Retired cardiologist calls for Congress to redefine nonprofit status for hospitals

A retired cardiologist argued in a recent editorial that hospitals’ competition for profits has been a major reason healthcare costs in the U.S. have become the highest in the world and continue to increase. He also called for Congress to redefine what a “nonprofit” hospital means.

Pages